v3.25.1

Summary of significant transactions - Equity Investments In Frontier Medicines (Details) - EUR (€) € in Thousands	Dec. 31, 2024	Dec. 31, 2023
Summary of significant transactions
Equity Investments	€ 52,941	€ 13,575

X

- Definition

Summary Of Significant Transaction [Abstract]

+ References

No definition available.

+ Details

Name:	glpg_SummaryOfSignificantTransactionAbstract
Namespace Prefix:	glpg_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The amount of investments in equity instruments that the entity has designated at fair value through other comprehensive income. [Refer: At fair value [member]; Other comprehensive income]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2024-01-01
-Paragraph 11A
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_11A_c&doctype=Standard
-URIDate 2024-03-27

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2024-01-01
-Paragraph 8
-Subparagraph h
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_8_h&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant